Passage Bio Reports Second Quarter 2022 Financial Results and Provides Recent Business Highlights

Go back to Passage Bio Reports Second Quarter 2022 Financial Results and Provides Recent Business Highlights

Passage Bio, Inc. (PASG) Tops Q2 EPS by 9c

August 4, 2022 7:53 AM EDT

Passage Bio, Inc. (NASDAQ: PASG) reported Q2 EPS of ($0.73), $0.09 better than the analyst estimate of ($0.82).

For earnings history and earnings-related data on Passage Bio, Inc. (PASG) click here.

... More